iBio Expands COVID-19 Vaccine Collaboration to Include the Infectious Disease Research Institute

    NEXT STORY
    Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development
    PREV STORY
    Aravive Announces Board Composition and Executive Management Transitions
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Lionsgate Implements Glenco’s protocol “Standard for Safe Set”

    author_avatar
    NASDAQ Market News

    Onconova Therapeutics, Inc. to Provide Corporate Update and Full Year 2017 Financial Results

    NEWTOWN, Pa., March 01, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase ...

    author_avatar
    NASDAQ Market News

    Kalytera Announces Initiation of Phase 2 Clinical Study in Prevention of Graft Versus Host Disease and Agreement with The Salzman Group of Israel to Manage and Partially Fund the Study to be Led by a World Class Team

    SAN FRANCISCO and TEL AVIV, Israel, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, ...

    author_avatar
    NASDAQ Market News